Levofloxacin Sandoz

Levofloxacin, the active ingredient in Levofloxacin Sandoz, is a fluoroquinolone antibiotic presented as an injectable solution for intravenous use. It treats a range of serious bacterial infections in adults, including community‑acquired and hospital‑acquired pneumonia, complicated urinary tract infections, intra‑abdominal infections, skin‑structure infections, and septicemia.

GNH USA supplies Levofloxacin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat severe bacterial infections across several organ systems.

- Community‑acquired bacterial pneumonia: rapid bacterial eradication to improve respiratory function. - Hospital‑acquired bacterial pneumonia: effective against resistant pathogens in critical care settings. - Complicated urinary tract infections: clears infection in upper urinary tract and kidneys. - Complicated intra‑abdominal infections: targets mixed aerobic and anaerobic organisms. - Skin and skin‑structure infections: resolves cellulitis, abscesses, and wound infections. - Septicemia: systemic bacterial clearance in bloodstream infections.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Injection site reactions: redness or pain at the IV site. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, often linked to sudden activity. - QT interval prolongation: may predispose to cardiac arrhythmias. - Clostridioides difficile infection: severe colitis after disruption of gut flora. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Seizures: particularly in patients with CNS disorders or on interacting drugs.

Levofloxacin requires careful assessment before use to minimise risks.

- Renal function assessment: dose adjustment may be needed in impaired kidneys. - Tendon monitoring: advise patients to report tendon pain or swelling. - Hypersensitivity check: avoid in individuals with known fluoroquinolone allergy. - QT prolongation caution: use cautiously with other QT‑prolonging agents. - Concomitant drug review: evaluate for interactions with NSAIDs, anticoagulants, and antacids. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with several medication classes, affecting safety or efficacy.

Major Interactions (Avoid): - Other fluoroquinolones: additive toxicity risk. - QT‑prolonging drugs (e.g., macrolides, antiarrhythmics): increased arrhythmia potential. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened CNS adverse effects. - Antacids containing aluminum or magnesium: reduced levofloxacin absorption. - Warfarin: may enhance anticoagulant effect and INR.

Moderate Interactions (Monitor Closely): - Corticosteroids: elevated risk of tendon rupture. - Cyclosporine: potential for increased nephrotoxicity. - Diabetic agents: possible alteration of glucose control. - Theophylline: may raise serum theophylline levels. - Oral contraceptives: reduced hormonal efficacy, consider backup contraception.